To Top

Search By Topic

Clinical Trial

184 Articles available
Clinical Trial

Research Ready™ Program Expands and Diversifies Clinical Trial Patient Populations

PR-M05-18-NI-065
Oncology

Roche’s TECENTRIQ (Atezolizumab) Receives Priority Review

PAO-M05-18-NI-009
Clinical Trials

Merck Provides Update on KEYNOTE-407 Trial

PR-M05-18-NI-026
Clinical Data

Study Shows AST-005 is Safe and Tolerable in Patients at Higher Doses than Previously Studied

PAO-M05-18-NI-003
Clinical Data

DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease

PR-M04-18-NI-004
Vaccine

Vaccibody moving forward with Cancer Neoantigen Vaccine Trial

PR-M04-18-NI-79
Oncology

New Breast Cancer Drug Accepted for Review by EMA

PAO-M04-18-NI-010
Clinical Trials

Eli Lilly Gets Good News for Cyramza

PAO-M04-18-NI-009
Clinical Trials

First Patient Treated in Pivotal Phase 3 Trial to Evaluate OTL38 in the Detection of Ovarian Cancer

PR-M04-18-NI-33
Clinical Trials

SELLAS Life Sciences Announces Positive Interim Data from Phase 2b NeuVax™ (nelipepimut-S) Clinical Trial

PR-M04-18-NI-020
Results

Positive Results for Pfizer Drug Tafamidis

PAO-M04-18-NI-001
Clinical Trials

Wize Pharma Enrolls First Patient in Phase IV Study of LO2A for Symptomatic Treatment of Dry Eye Syndrome in Patients With Sjögren's Syndrome

PR-M04-18-NI-005
Clinical Trials

Final results from landmark DYNAGITO® trial published in The Lancet Respiratory Medicine

PR-M04-18-NI-001
Clinical Data

Clinical Study Data for New MS Drug Looks Promising

PR-M03-18-NI-101
Clinical Trials

BrainStorm Cell Therapeutics' Phase 3 Trial of NurOwn® in ALS Now Open to Canadian Patients

PR-M03-18-NI-108
Clinical Data

New Study finds younger aged children with symptoms of ADHD have reduced brain size

PR-M03-18-NI-101
Clinical Trials

Clinical Trial Access to Expand Following Receipt of Additional Funding    

PAO-M03-18-NI-026
Clinical Data

Phase III data in The Lancet show Novartis siponimod significantly improved outcomes in patients with secondary progressive MS

PR-M03-18-NI-095
Clinical Trials

Pfizer Reports Top-Line Results from a Study of CHANTIX®/CHAMPIX®  (varenicline) in Adolescent Smokers

PR-M03-18-NI-093
Clinical Trials

AbbVie Announces Results from Phase 2 Study Evaluating Rovalpituzumab Tesirine (Rova-T)

PR-M03-18-NI-088
Clinical Trial Data

Favorable safety profile of Pradaxa® (dabigatran etexilate) confirmed in large prospective real-world analysis

PR-M03-18-NI-086
Clinical Trials

Late-breaking Clinical Trial Data Further Demonstrate Safety and Effectiveness of the RHYTHMIA™ Mapping System

PR-M03-18-NI-083
Acquisition

Worldwide Clinical Trials Acquires Continuum Clinical’s Late Stage Research Practice

PR-M03-18-NI-065
Research

PAREXEL and CHA Medical Group Partner to Enhance Early Phase Clinical Research in Korea

PR-M03-18-NI-056
Clinical Trials

AbbVie Announces Positive Topline Results from Second Phase 3 Study Evaluating Investigational Elagolix in Women with Uterine Fibroids

PR-M03-18-NI-057
Innovation

Bruker and Evosep Announce New Integrated Clinical Research Proteomics Solution to Quantify Over a Thousand Proteins in Five Minutes

PR-M03-18-NI-051
Acquistion

Biogen to Acquire from Pfizer First-in-Class Phase 2b Ready Asset for Cognitive Impairment Associated with Schizophrenia

PR-M03-18-NI-049
Laboratory Testing

Creating Comprehensive Solutions through Laboratory Testing

PAP-Q1-18-CL-011
Supply Chain

Overcoming Challenges in the Complex Market for Clinical Trials and Clinical Logistics

PAP-Q1-18-CL-010
Results

Lilly Reports Results of Migraine Survey

PAO-M03-18-NI-007
Innovation

Results of Landmark Wearable Defibrillator Trial to Be Presented as ACC.18 Late-Breaker

PR-M03-18-NI-026
Clinical Trials

Gilead Announces Data from New Preclinical Study Evaluating a Combination of an Investigational TLR7 Agonist and an Investigational HIV Envelope

PR-M03-18-NI-021
Clinical Trials

The UPS Store, Marken Team Up For Drop-Off Service For Clinical Trial Samples In U.S.

PR-M03-18-NI-007
Drug Development

HEPAXA is a New Treatment in the US from BASF for Patients with NAFLD

PAO-M02-18-NI-023
Influenza

GSK presents new efficacy data for FLUARIX® QUADRIVALENT (Influenza Vaccine) in children 6 months through 35 months of age

PR-M02-18-NI-87
Clinical Trials

Aimmune’s AR101 Meets Phase 3 Endpoints

PAO-M02-18-NI-020
Clinical Trials

AbbVie Announces New Phase 2 Data for Upadacitinib Showing Clinical and Endoscopic Outcomes in Crohn's Disease at 52 Weeks

PR-M02-18-NI-83
Oncology

Device Plus Drug Approved for Bladder Cancer Detection

PAO-M02-18-NI-018
Clinical Trials

Breakthrough Scar Treatment in Clinical Trials

PAO-M02-18-NI-016
Clinical Trials

Mallinckrodt Enrolls First Patient in Phase 1 Study of ExpressGraft™C9T1 Skin Tissue

PR-M02-18-NI-74
Clinical Trials

Encorafenib and Binimetinib Combination Treatment Demonstrates 33.6 Month Median Overall Survival (OS) in Patients with BRAF-Mutant Melanoma

PR-M02-18-NI-043
Clinical Trials

Tyzivumab is Ready for Trials

PAO-M02-18-NI-011
Market Expansion

Marken Accelerates Its Reach And Growth In Clinical Trial Logistics

PR-M02-18-NI-031
Clinical Trials

COPD Patients Excited about AstraZeneca Trial Results

PAO-M02-18-NI-002
Fast Track

FDA Grants Fast Track Status to Takeda’s Zika Vaccine Candidate

PAO-M02-18-NI-003
Clinical Trial

Amgen and Novartis Reach an Important Milestone

PAO-M01-18-NI-041
Oncology

Overall Survival Analysis From KYPROLIS® (Carfilzomib) Phase 3 ASPIRE Trial Published in the Journal of Clinical Oncology

PR-M01-18-NI-074
Clinical Trials

Celerion Creates a Fully Automated, Early Development Clinical Trial Data Management Platform

PR-M01-18-NI-070
Expanded Capacity

Marken Opens New Kit Building Facility In Shanghai

PR-M01-18-NI-057
Treatment

First Treatment for MERS Appears Safe in NIH Phase I Clinical Trial

PR-M01-18-NI-041
Research

Medical Research Collaborating Center Selects Medidata to Meet Global Regulatory Requirements During Clinical Trials

PR-M01-18-NI-037
Clinical Trials

BerGenBio Meets First Efficacy Endpoint in Phase II Trial With Selective AXL Inhibitor BGB324 (bemcentinib) in NSCLC

PR-M01-18-NI-035
Bioequivalence Study

Biohaven Announces Positive Results From Bioequivalence Study With Sublingual BHV-0223 Zydis® Orally Dissolving Tablet

PR-M01-18-NI-034
Biologics

New Class of Exosome Biologics Focuses on Stroke Treatment

PAO-M01-18-NI-011
Drug Discovery

Defense Department Commits $16 Million to Fight Bacterial Bioweapons

PAO-M01-18-NI-010
Clinical Data

DNAnexus Announces $58 Million Investment to Accelerate Expansion

PR-M01-18-NI-004
Clinical Trials

Centrexion Therapeutics Raises $67 Million; Launching Phase 3 Program for CNTX-4975 in Knee Osteoarthritis Pain in 2018

PR-M01-18-NI-002
Strategic Partnership

Mitochondrial Expert Mitobridge Snapped Up by Astellas Pharma

PAO-M01-18-NI-002
Biosimilars

Pfizer Receives FDA Approval for Remicade® Biosimilar

PAO-M12-17-NI-039
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
Investment

Transporters Targeting Cell’s Metabolic Gates Win Financing

PAO-M12-17-NI-037
Drug Delivery

Needle-Free Injection Technology Advances to Phase II Trial

PAO-M12-17-NI-035
FDA

NDA Submitted for Antimalarial Drug

PAO-M12-17-NI-034
Research

Tumor Killing Combo Wins Third U.S. Patent

PAO-M12-17-NI-033
Drug Development

Chinese Biopharma Receives Series A Financing

PAO-M12-17-NI-031
Strategic Partnership

BioVectra and Keryx Expand Strategic API Supply Relationship

PAO-M12-17-NI-030
Innovation

Renova Therapeutics' Gene Transfer Tech Enters the Fast Lane

PAO-M12-17-NI-028
Clinical Trials

Novo Nordisk Bags FDA Approval for New Diabetes Treatment

PAO-M12-17-NI-024
Oncology

Phase III Study Confirms AbbVie Leukemia Combo Meets Endpoint

PAO-M12-17-NI-021
Clinical Trial

Hovione Announces Enrollment of First Patient in MARS a Phase 2 Clinical Trial 

PR-M12-17-NI-005
Immuno-oncology

Genentech and Biothera to Assess Combination Cancer Therapy

PAO-M12-17-NI-010
Clinical Trial

Zika Vaccine Candidate Enters Phase I Trial

PAO-M12-17-NI-008
Investment

Bellwyck and Faller Establish Joint Venture in Germany

PR-M11-17-NI-015
FDA Approval

AstraZeneca’s Anti-Asthma FASENRA Wins FDA Approval

PAO-M11-17-NI-038
FDA

First Treatment for Rare Blood Disorder Approved by FDA

PAO-M11-17-NI-026
Strategic Partnership

QuintilesIMS Now IQVIA

PAO-M11-17-NI-024
Acquisition

Mallinckrodt Expands Pipeline with Ocera Therapeutics Buy

PAO-M11-17-NI-020
Research

Fertility Experts: Embryos Travel Better Frozen

PAO-M11-17-NI-012
Pregnancy Tracker

Ovarian Cycle Bracelet Detects Pregnancy in Trials

PAO-M11-17-NI-010
Clinical Trials

FDA Lifts Clinical Hold on Cellectis Phase 1 Clinical Trials with UCART123 in AML and BPDCN

PR-M11-17-NI-001
Cell and Gene Therapy

Segregation in the Design of Gene Therapy Manufacturing Facilities

PAP-Q4-17-CL-002
Clinical Trials

Managing the Complexities of Outbound Clinical Drug Distribution

PAP-Q4-17-CL-001
FDA Approval

First Treatment for Generalized Myasthenia Gravis Approved After 60 Years

PAO-M10-17-NI-039
Oncology

Study Finds Beta Blockers Interrupt Nerves Sustaining Prostate Tumor Growth

PAO-M10-17-NI-036
FDA

BioMarin Highlights Advanced Genetic Disease Therapy Pipeline

PAO-M10-17-NI-035
Clinical Trials

Alzheimer’s Clinical Trial Focused on Restoring Lost Brain Connections

PAO-M10-17-NI-028
Supply Chain

IEEE Releases First Detailed Study of Blockchain Technology in Pharma

PAO-M10-17-NI-027
Clinical Trials

Connected Clinical Trial Online Platform Launches

PAO-M10-17-NI-026
Vaccine

Leprosy Vaccine in Human Trials

PAO-M10-17-NI-021
Clinical Trials

Greenovation Biotech GmbH Announces Completion Of Its Phase I Safety Study For moss-aGal Targeting Fabry Disease

PR-M10-17-NI-005
Innovation

Bone Marrow Transplant Therapy Gets Monoclonal Antibody Boost

PAO-M10-17-NI-015
Innovation

Trial for Cancer Treatment Using Microscopic Beads Begins

PAO-M10-17-NI-014
Cell and Gene Therapy

Gene Therapy Stabilizes Neurodegenerative Disease

PAO-M10-17-NI-013
CRO

Society for Clinical Research Sites Announces Winning Sponsor and CRO of 2017 Eagle Award — Eli Lilly and INC Research/InVentiv Health

PR-M10-17-NI-006
Vaccine

Study Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine

PR-M10-17-NI-003
Drug Development

New Insulin Formulation Improves Mealtime Glycemic Control

PAO-M10-17-NI-011
FDA

FDA Attracts Big Tech Companies in Effort to Develop Digital Health Apps

PAO-M10-17-NI-005
Clinical Trials

GSK and Innoviva Present Positive Results from Pioneering Asthma Study

PAO-M09-17-NI-020
Clinical Trials

Veeva Vault eTMF Helps Cancer Research UK Improve Clinical Trial Efficiency and Compliance

PR-M09-17-NI-003
Clinical Logistics

Managing the Complexity of Global Clinical Logistics for Next-Generation Personalized Medicines

PAP-Q3-17-CL-007
CRO

Building Strategic Sponsor-CRO Partnerships: The International Element Changing Clinical Trials

PAP-Q3-17-FA-002
Drug Development

Cladribine Demonstrates Disease Control with Shorter-Course Treatment

PAO-M09-17-NI-015
Clinical Data

Results from the INJOURNEY™ trial investigating Ofev® with add-on pirfenidone provide new insights into this combination treatment for IPF

PR-M08-17-NI-012
Innovation

Post-Approval Studies Confirm Therapeutic Value of Oral Anticoagulants

PAO-M09-17-NI-005
Oncology

Vitamin C: Prostate Cancer’s New Foe

PAO-M08-17-NI-039
Clinical Trials

Bonti Announces Start of LANTERN-1 Phase 2 Clinical Study Evaluating EB-001 in Reducing Musculoskeletal Pain

PR-M08-17-NI-007
Clinical Trials

Novel Pneumonia-Fighter Enters Pivotal Trial

PAO-M08-17-NI-011
Innovation

Regenerating Knee Cartilage with Stem Cells

PAO-M07-17-NI-020
Drug Development

New Partnership Targets Colorectal Cancer with Combination Therapy, Including Avelumab

PAO-M06-17-NI-020
CRO

CRO’s Move to Fill the Gap

PAO-M06-17-NI-006
Continuous Manufacturing

Cardio Candidate to be Manufactured Continuously

PAO-M06-17-NI-003
Clinical Trials

Clinical Trials Find a Device for Growth

PAP-Q2-17-FA-002
Clinical Trials

HIV Vaccine Demonstrates “Remarkable” Rates

PAO-M05-17-NI-039
Clinical Trials

Priority Review Given to Kite’s Axicabtagene Ciloleucel

PAO-M05-17-NI-034
Clinical Trials

CFDA Calls for Clinical Trial Reform

PAO-M05-17-NI-025
Clinical Trials

New Licensing Agreement Could Lead to Improved Brain Cancer Treatment

PAO-M05-17-NI-017
Clinical Trials

Harmonized Protocol Templates Available for Clinical Trial Sponsors

PAO-M05-17-NI-013
Clinical Trial

Expanding Into Clinical Trials

Jeff Schwegman, CEO, AB Biotechnologies 

PTV-M03-17-IN-012
Clinical Trials

Advancing Clinical Trial Efficiency with Electronic Informed Consent

APR-M03-17-NI-001
Supply Chain

Direct to Patient Logistics and Technology

Paddy Hanlon, Vice President, Commercial Operations East Coast & Canada, Marken

PTV-M01-17-NS-003
Clinical Trials

Verona Turns to QuintilesIMS for Drug Development

PAO-M03-17-NI-004
Clinical Trials

FDA Approves Bavencio for Rare Skin Cancer

PAO-M03-17-NI-002
Discovery

Big Data: A Big Challenge

PAP-Q1-17-NO-001
Outsourcing

Spending on Contract Research Services Slowing Down

PAP-Q1-17-FA-003
Supply Chain

Keeping the Chain Going

PAP-Q1-17-FA-007
CDMO

Q: What Challenges are Associated with Implementing Cloud Computing within CROs/CDMOs?

PAP-Q1-17-RT-004